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Abstract
Background: In South Korea, the Health Insurance Review and Assessment Service manages the Prescribing
Analysis System (PAS) to evaluate the appropriate use of medication. To achieve the system’s goal of changing
prescribing behavior, it is critical to understand how physicians respond to the PAS. This study analyzes the
opinions of South Korean physicians about the PAS, the way it is used, and factors affecting prescribing behavior.
Methods: A qualitative, exploratory approach was used, with four focus groups of physicians from different
specialties. A semi-structured guide was used to explore their opinions. Transcripts of the discussions were analyzed
by the authors, who independently considered content using uniform categories. Common themes were extracted
and used to gather results and draw conclusions.
Results: Physicians acknowledged some positive aspects of the PAS but, overall, had mainly negative impressions
of the system, and particularly, the evaluation reports that it generates. They reported that their prescribing
behavior was affected by predisposing factors, including experiential, environmental and psychological factors.
Physicians reported that their negative perceptions regarding the regulations were primarily influenced by concerns
about maintaining their autonomy and expertise. However, their strong resistance to these perceived infringements
on their independence may be considered inconsistent in relation to their professional autonomy as there was an
equally strong concern about market competition. Physicians’ objections to the PAS are more likely to have been
caused by deeply rooted distrust of the government agency in charge of the system.
Discussion: Interestingly, we found that physicians’ strong resistance to perceived violations of their autonomy
seems somewhat inconsistent and contradictory. While they are very positive about new information or printed
materials provided by pharmaceutical representatives, they are less enthusiastic when it comes to governmental
guidelines or standards. Similarly, they appear to willingly accept situations in which they believe they should
comply with patients’ demands as a means of surviving in a competitive market. It is notable that physicians’
negative perceptions of PAS seemed to be aggravated by suspicion and distrust regarding the purpose of this
program.
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Conclusions: Because of widespread beliefs in professional autonomy, market competition, and a deep-seated
distrust of the system, it would be difficult for the government to persuade physicians to change their prescribing
behaviors using only the PAS. Successful implementation of the PAS will not only require its improvement as a
policy tool, but also the creation of a social consensus regarding the PAS.
Keywords: Trust in government, Prescribing Analysis System (PAS), Focus Group Interview (FGI), Prescribing
behaviors, Policy implementation, Policy tools
Background
According to the World Health Organization (WHO), ra-
tional use of drugs means that patients receive medication
appropriate to their individual clinical needs in the right
dosage for an adequate period of time at the lowest pos-
sible cost [1]. To improve rational drug prescribing, sev-
eral countries have implemented a prescribing monitoring
system. For example, the UK, Spain, and Sweden use na-
tional prescribing monitoring and feedback systems. Their
prescribing indicators include the percentage of generic
prescribing, cost of statin prescriptions, and antibiotic pre-
scribing rates.
However, physicians’ behavior has not necessarily chan-
ged since the introduction of these systems. Worldwide,
approximately two-thirds of all prescriptions for antibi-
otics prescribed by physicians are known to be for the
treatment of respiratory tract infections (RTIs) [2].
According to Gulliford et al. [3] antibiotics are prescribed
for 36.5 % of common colds in the UK, 48.7 % in France
[4], 39.7 % in Spain [5], 16 % in Holland [2], and 7 % in
Sweden [6]. When Akkerman et al. [7] surveyed 146 phy-
sicians to find determinants of antibiotic overprescribing
for sinusitis, tonsillitis, and bronchitis patients, only 50 %
of them reported following national guidelines, which in-
dicate that antibiotics should not be prescribed for com-
mon colds.
Antibiotic prescription abuse is also a serious issue in
South Korea. In 2000, the total antibiotic prescribing rate
was 57.9 % [8]. In 2002, the antibiotic prescribing rate for
the common cold was 73.33 %, and the total antibiotic
prescribing rate was 42.39 % [9]. Nonsteroidal anti-
inflammatory drugs and corticosteroids also have some
issues related to overuse [10, 11]. As a response, in 2001,
South Korea introduced the Prescribing Analysis System
(PAS) to promote appropriate prescribing. It is not yet
clear, however, that the program has produced sufficient
changes in prescribing behavior. For example, in 2013, the
average rate of antibiotic prescription for upper respira-
tory tract infections by private clinics was substantially
higher than in tertiary hospitals (43.33/hundred visits vs.
23.99/hundred visits, respectively) [12].
In this research, we aimed to understand the impact of
the PAS on physician behavior, and whether it has the
potential to reduce pharmaceutical misuse or abuse and
manage pharmaceutical expenditure by reducing unneces-
sary and inappropriate prescriptions. We attempted to
identify factors affecting physicians’ prescribing patterns,
examined their perceptions of the PAS, and assessed the
system’s strengths and limitations. Our research questions
were: 1) What factors do physicians report as affecting
prescribing behavior? 2) What are physicians’ perceptions
of the PAS? 3) Do physicians perceive the program to be
effective? If not, what are the main reasons? and 4) Are




We conducted focus group interviews on May 7–14,
2009. Four medical specialty areas were identified as
having the most outpatient visits and prescriptions in the
Seoul and Kyungki-do areas: internal medicine, otorhino-
laryngology, pediatrics and primary care. We recruited 28
physicians across the specialties and geographical areas,
and 27 agreed to participate in the study. They were
divided into four focus groups by specialty, each consist-
ing of six to seven physicians. In each focus group, partici-
pants’ ages ranged from 39 to 56 with an average age of
40. There were two females and 25 males. The gender
distribution of primary care physicians in South Korea is
86 % male and 14 % female. Six participants worked in the
Kyungki-do area, and the rest in Seoul (Table 1).
Focus group interview questions were generated by
literature review and discussion among the authors of this
study. Participants were asked to reflect on their prescrib-
ing behavior and their experiences and perceptions of the
PAS. In each focus group, a group discussion lasting one-
and-a-half hours was conducted on the following topics:
1) determinants of prescribing behavior; 2) perceptions
and attitudes toward the PAS; 3) PAS indicators; 4) feed-
back methods used by the PAS; and 5) overall opinions
and comments about the system.
Interviews were conducted at a research center with
videotaping facilities. Two of the authors, who are health
policy researchers and familiar with government decision-
making processes, moderated the focus group discussions
as facilitators. Other researchers participated in the focus
group as observers.
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The study was approved by the Health Insurance Re-
view and Assessment Service’s (HIRA) Institutional
Review Board. Informed consent was obtained from the
participants at the beginning of each session. Pseudonyms
were used in data analysis to protect participants’
anonymity.
Coding and analysis
Focus group interviews were videotaped and transcribed
verbatim by a professional transcriber. All four researchers
monitored the interviews and, upon completion of each
one, wrote reflective notes and memos. The researchers
conducted hour-long sessions for debriefing and discus-
sion, following the completion of each group interview.
The four resulting transcripts were coded by all four au-
thors. We used open-coding of transcripts to identify key
words, phrases, and statements. As far as possible, the
codes and categories were created for consistency in
reflecting emerging ideas, rather than merely describing
topics. In the initial line-by-line coding process, re-
searchers tried to observe data analytically without
preconceived assumptions. Through iterative reading, we
identified repeated and notable words, phrases, and pat-
terns among the participants’ responses. Several common
themes emerged from the first stage of ‘interpretive’ read-
ing, while others emerged during, or as a result of, several
additional rounds of reading. We then collapsed the codes
and categorized them into themes by similarity of mean-
ing within our research questions. Disagreements and dif-
ferences in describing, synthesizing, and explaining the
data were resolved by continuous discussions. Emerging
codes, categories, and themes were entered into matrices
by specialties to enable comparisons and contrasts within
and among groups.
Prescribing Analysis System (PAS)
The South Korean government adopted the PAS in 2001
to reduce misuse and abuse of prescription medicines,
and to promote proper usage, by improving each institu-
tion's autonomous management of medication. There are
indicators to measure performance in three categories,
including antibiotic prescription, injection frequencies,
and the medication cost per day of use, which have been
tracked and recorded since 2001. Later additions include
the number of items per prescription (2003), the propor-
tion of high-priced prescriptions (2003), and the duplica-
tion rate of NSAIDs (2005) (Table 2). The PAS reports
prescribing tendencies of medical care institutions in a
comparative format and provides feedback to each
institution.
Consumers can also see information about PAS results
to help them make informed choices when selecting a
medical care institution. Since 2006, indicator results,
such as the number and the rate of Caesarean sections
at each institution, have been openly reported.
Table 2 Indicators used in the Prescribing Analysis System (PAS)
Categories Indicators
Injections Injection prescription rate
Antibiotics Antibiotic prescription rate
(all diseases)
Prescription rate for acute
upper respiratory infections
No. of drugs per
prescription
No. of drugs per prescription
(for all diseases)
No. of drugs per prescription
(respiratory diseases)
No. of drugs per prescription
(musculoskeletal diseases)
Prescription rate with 6 or
more items




Medication cost per day of use
Prescribing expensive
medications
Proportion of prescribing of
high-priced medicines
Proportion of cost of high-priced
medicines
NSAIDsa and steroids for
osteoarthritis
Duplicate prescription rate for
NSAIDs
Prescription rate for steroids
aNSAIDs Nonsteroidal anti-inflammatory drugs
Table 1 Characteristics of participants
Total Participants
Internal medicine specialist Otorhinolaryngologist Pediatrician Primary care physician
(G1) (G2) (G3) (G4)
No. of participants 27 7 7 7 6
Average age (years) 49.3 42.6 46.9 46.5
Age range (years) 44–51 39–50 41–56 44–48
Gender: male/female 25/2 6/1 7/0 7/0 5/1
Location: Seoul/Kyungki-do 21/6 7/0 6/1 4/3 4/2
Unit: Number of people, ages in years
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Results
Models of our study on physicians’ perceptions of the
PAS, its effects on their behavior, and their responses are
summarized in Table 3.
Predisposing factors of prescribing behavior
The focus group participants reported that their prescrib-
ing behavior was affected both by training received during
their residency periods and knowledge accumulated
through clinical experience (experiential factors). Their
behavior was also affected by patient demands, market
trends, and information from seminars or pharmaceutical
companies (environmental factors).
Clinical autonomy, based on training and accumulated
experience
Participants indicated that the most important determin-
ing factor was their professional judgment, based on clin-
ical training and accumulated personal experience. They
stressed that physicians observe the effects of antibiotics
many times in their clinical practice. They emphasized
that what they learned during their training is strongly
ingrained, so it would be hard for them to be open to
other inputs.
“Physicians prescribe antibiotics according to what they
learned and what they think works. Physicians have
their own background for their decisions.” (G1-a)
“My training was in the respiratory system. As I was
taught, I now prescribe inhalants often.” (G1-b)
Participants also argued that diagnosis and prescription
may differ for the same symptom or disease, depending
on the prescribing physician’s specialty. For example, for
symptoms resembling a common cold, prescribing deci-
sions depend on the physician’s specialty—primary care,
pediatrics, or otorhinolaryngology—resulting in different
diagnoses and treatment.
“Otolaryngologists prescribe antibiotics more often
than other specialties. Pediatricians don’t prescribe
antibiotics as much. It is because we have many
patients who need antibiotics. We have a higher
proportion of patients with infections.” (G2-a)
Participants were concerned that the PAS could result in
a uniformity that disregards differences between specialties.
Patient demands in a competitive market
Regardless of their specialties, participants acknowledged
that patient demands were another important factor that
affected their prescribing behavior. The participants sug-
gested that, to patients, quick recovery or restoration to
health is most important, and this affects patients’ choice
of clinics and physicians (‘physician shopping’). Physicians
worried that if these expectations were not met, patients
could make claims against them. They also asserted that
quick recovery is a critical factor in building trust between
physicians and patients.
“Maintaining a good relationship with my patients is
the most important issue for me. If it is ruined, then
nothing works out. I have no other choices.” (G4-a)
Table 3 Physicians’ perceptions and reactions to the PAS and determining factors




● Training received during residency periods ● Increased consciousness of their own
prescribing behavior
● Initially paying attention to the reports, but
beginning to ignore them over time
● Accumulated knowledge through their clinical
practice
● Acknowledge the need for appropriate
prescription guideline
● Following market trends and/or patient
demands instead of cooperating fully
with the PAS
Environmental factors
● Patient demands ● Concerned about violation of their
professional autonomy and expertise
● Play smart by up-coding for losses
● Market trends ● Dissatisfied with indicators and ranking
methods of the PAS
● Uses non-reimbursable treatment or gives
up requesting claims for treatment provided
● Information from seminars or pharmaceutical
companies
Sociopsychological factors
● Distrust of true intentions and purpose of PAS ● Dissatisfied with methods of notification
● Distrust of HIRA ● Apprehensive about releasing PAS results to
the public
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Participants admitted that they kept records of patients’
preferences for injections or antibiotics in medical re-
cords, and prescribed according to preferences. In particu-
lar, geriatric patients were known to prefer injections;
therefore these were more frequently provided.
“My injection prescription rate is in the highest range.
However, the mean age of my patients is 75 years old.
If I refuse to prescribe injections, they get angry.
Some cry. Others complain that I don’t respect them.
What can I do? Female elderly patients don’t come
back if I say ‘no’ to them.” (G4-b)
“Nurses in my clinic told me that I was notorious among
patients. When I was in the bottom 20th percentile [in
terms of prescribing injections], patients didn’t come
back. So I made some changes. Then the number of
female elderly patient visits increased. My score now is
around the 40th to 50th percentile.” (G4-c)
These opinions seem to contradict the participants’ pre-
vious comments that they prescribe according to their own
expertise and professionalism. It seems that, in practice,
physicians’ expertise and autonomy do not always take pre-
cedence over patient demands. Participating physicians
stated that prescribing antibiotics is unavoidable because
patients choose physicians who will provide their preferred
treatment. Physicians’ prescribing behavior is very affected
by patient demands, especially when they work in a com-
petitive medical market. Abundant information available
through the internet and mass media appears to influence
patients, so that they make direct requests for specific
medication. Both an otorhinolaryngologist and a primary
care physician pointed out that market competition caused
difficulties for them. They reported that it is often very tir-
ing and time-consuming to persuade patients asking for
antibiotics or injections that this medication is not appro-
priate for their condition. In a competitive market, adher-
ing to government guidelines makes their work difficult.
“Competition between private clinics is very intense.
In the case of GPs, patients don’t wait for us just as
they do in university hospitals. If they don’t feel better
within one or two days, they just go to see another
physician. That’s why GPs tend to prescribe high-
priced drugs, antibiotics, injections, or steroids more
often in the initial treatment.” (G4-d)
“When I first opened the clinic, I followed what I learned
from my school or guidelines from doctors’ associations
or HIRA. After one year of practice, the number of
patient visits fell to one third. There are so many GPs in
my town. If I say injections are not necessary for the
patients, they go to another clinic up the road.” (G4-e)
“Mothers insist on branded medicines, even if I
prescribe generic drugs. For example, if I prescribe
generic drug A to a child, the mother will ask me to
prescribe B from company C instead.” (G3-b)
Those who said patient demands played a huge role in
their prescribing behaviors argued that patient education
is vital to changing prescribing practices. Physicians
argued that the government should start a campaign of
patient education on the appropriateness of particular
medication for various illnesses.
Influence of seminars and pharmaceutical companies
Information from seminars, academic conferences, or
pharmaceutical companies also influences the prescribing
behavior of physicians. Our analysis indicated that physi-
cians’ prescribing behavior is often influenced by pharma-
ceutical companies’ marketing strategies. Patients often
prefer brand name drugs that they have learned about
from TV advertisements, while physicians rely on pharma-
ceutical companies’ marketing materials. In general, par-
ticipating physicians showed a low level of trust in
bioequivalence tests conducted in South Korea between
generic and branded drugs.
Physicians’ perceptions of the PAS
Positive perceptions
Regardless of their specialty, participants in all four groups
made some positive remarks about the PAS. They re-
ported that the system has been helpful in enabling them
to compare their own prescribing behavior with others.
Participants also acknowledged the over-use of antibiotics
and injections in South Korea. Most of them, including
those who had a negative attitude toward the PAS, agreed
that changes are necessary. Several participants said that if
the program is based on relevant indicators and employs
correct data, it has the potential to change physicians’ pre-
scribing behavior.
Distrust of the PAS’s intentions and purpose
Overall, participants stressed more negative than positive
aspects of the PAS. They described it as another ‘top-
down’ managerial intervention by the government. They
also had strong suspicions about its purpose. The stron-
gest criticism of the system was whether it was designed
to improve the quality of medical services or reduce
pharmaceutical expenditure. Most of the participants
seemed to assume that its main purpose was to reduce
pharmaceutical expenditures, while bolstering the finan-
cial security of the National Health Insurance Corpor-
ation. Participants therefore expressed antagonistic
attitudes toward the use of indicators that measure how
often physicians prescribe lower-priced drugs, asserting
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that these indicators may promote prescription of ‘cheap’
drugs and degrade the quality of medical services.
Many participants said that it is beneficial to be known
as someone who prescribes high-priced medicines. They
do not want to be known as physicians who are more
concerned about cost savings than effective treatment.
“I feel like they are forcing us to prescribe cheap
drugs. It is not about improving the quality of medical
services but all about drug cost savings. It may help to
cut out unnecessarily prescribed drugs, but they
excluded all the complex medicines from the positive
list. What can I do if I need to prescribe complex
medicines for the patient?” (G2-b)
“I am not sure if what they want is appropriate
pharmaceutical prescriptions or cost savings.” (G3-a)
Deeply rooted distrust of the Health Insurance Review and
Assessment Service (HIRA)
Our analysis revealed deeply rooted distrust of the PAS
and of HIRA, the agency in charge of the PAS. Study
participants reported experiencing unpleasant pressure
from, and dissatisfaction with, PAS. Most participants
used negative terms such as “threat”, “daunting”, and
“pressured” when they described the PAS.
“Auditing intimidates me. I feel I am monitored all the
time, which makes me very uncomfortable. I am
stressed out. I worry that I may get into trouble.” (G2-c)
“When I received the report from HIRA, it was like
receiving a silent threat.” (G4-d)
This well-established distrust seems to come from a lack
of effective communication between HIRA and physicians.
“In the end, it is all about partnership. If they are not
ready to listen to physicians, it is really a serious
problem…whenever we hear that there is a problem,
their answer is simple. ‘It’s already been decided.’”
(G3-a)
Concerns about violation of autonomy and expertise
Similar to the findings of most studies on physicians’ atti-
tudes toward any controlling mechanism [13–15], nega-
tive attitudes among physicians in our study appeared to
arise from a deeply held belief in clinical autonomy. All
participants, regardless of specialty, argued that prescrib-
ing decisions should not be controlled by a third party but
be based on the expertise of physicians. They claimed to
prescribe in line with their medical beliefs as professional
physicians, even if this was contrary to guidelines.
“I’m not sure what the word ‘appropriateness’ really
means here. I made the decision based on my
professional judgment of patients’ conditions and
status, so this is a matter between a physician and his/
her patient. It is not a matter in which a third party
should interfere. The government often thinks that
everybody should perform in the same way according
to the standardized guidelines, but there are cases that
are far from the standard. In my view, only my patient
and I can decide what is an appropriate treatment for
a specific situation.” (G4-c)
Most of the participants believed that the PAS forces
them to prescribe treatment based on rules, and that
one result of this single-standard system is a lower qual-
ity of medical services.
“The biggest problem with this system is that it may
unify all the medical services to a single standard. The
system forces us to just follow standardized medical
practice guidelines, provided by HIRA, even when
they are not consistent with newly published
information.” (G1-a)
Dissatisfaction with PAS indicators and implementation method
All participants pointed out that, to improve the PAS, valid
indicators should be developed and applied. They com-
plained that current indicators do not accurately reflect the
quality of medical services. Participants felt that they were
evaluated unfairly, based on distorted data. They also ar-
gued that the PAS should only check whether physicians
meet the criteria or not, rather than ranking them.
“For J06 laryngotracheobronchitis, a steroid should be
prescribed. However, from J00 to J06, they fall under
the same category of the PAS. Physicians have pointed
this out many times but it hasn’t changed yet.” (G3-a)
“Statistics or indicators are all about controlling
physicians. Ranking physicians from 1 to 100 does not
make sense at all.” (G2-d)
Participants also pointed out that the current system,
which allows physicians to register only the main diag-
nosis when they process claims, gives them an incentive
to distort claims.
“[with the current system] there is no way to
differentiate between main and sub diagnoses. Some
patients may need two or three injections for different
diagnoses. When a hypertensive patient came to me
because of a nosebleed, I had to register
‘hypertension’ as the diagnosis.” (G2-e)
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Most of the participants did not have sufficient under-
standing of the evaluation indicators and how they are cal-
culated. They expressed vague fears about receiving the
PAS results because they had not been clearly informed
about the penalties for a low score. This indicates that the
purpose, evaluation criteria, and implementation methods
of the PAS are not effectively communicated to physicians.
“Is there any penalty for those who get low scores?”
(G1-c)
“Many physicians don’t know which one [i.e.,
medication] is a high-priced drug or what the exact
purpose is [of collecting data regarding the] prescrib-
ing rates of high-priced drugs.” (G2-b)
Participants also complained that they did not know
where to find such information.
Dissatisfaction with the notification method and the
publication of results
Regardless of their specialty, most of the participants
were hostile to the PAS’ use of the term “Notice” and
suggested that the title of the “Grade Report” should be
changed to a more neutral one such as “Reference” or
“Results”. At the same time, they said that publishing re-
sults openly to those without the appropriate medical
knowledge to properly evaluate the information, is an
unwelcome challenge to their medical expertise.
“I don’t think ‘evaluation’ is the right term for this
system. The term implies that they investigate who did
right and who did wrong. The name should be changed
to ‘trend research’ or something like that.” (G1-a)
“The result should not be open to the public. Can you
explain to me what an upper or lower respiratory
system is? Releasing results to the public, most of
whom don’t have medical expertise, can distort the
image of the whole healthcare system.” (G3-c)
Participants also had critical opinions of the report for-
mat and the evaluation cycle. They preferred graphs and
figures to numerical values. Many suggested that evalua-
tions should be conducted once, in the fourth quarter, or
perhaps twice a year. For the PAS to be effective in
changing physician behavior, they suggested that better
feedback methods should be developed. Most physicians
do not understand the recommendations which accom-
pany the PAS results. They also thought that there should
be appropriate incentives to motivate physicians to change
their prescribing behavior. Physicians would be motivated
to do so if they could expect positive evaluations and
encouragement through rewards such as an excellent
clinic certification.
Discussion
This study was conducted to understand how South
Korean physicians perceive the PAS. A total of 27 partici-
pants from internal medicine, otorhinolaryngology,
pediatrics, and primary care were interviewed to identify
factors determining physicians’ prescribing behavior, and
the effects of the PAS on this, together with their response
to the program. Like previous studies on factors affecting
prescribing behavior [16–19], we found that South Korean
physicians’ prescribing behavior is determined by both in-
ternal and external factors, including their training and
experience [20], patient expectations and demands [21],
competitive market forces [22], and promotion and mar-
keting [23].
Most of the participants in this study had negative per-
ceptions of the PAS, stemming from a belief that the
reports were distorted by inadequate data collection or in-
terpretation. This result is similar to findings in the study
of Jones et al. [18], which found that UK physicians sel-
dom use the prescribing analysis and cost data from the
Prescription Pricing Authority [24]. However, Axelsson et
al., who studied 603 physicians in Sweden, reported that
attitudes to the prescribing guidelines were very positive;
42 % of physicians used the guidelines every day, and 34 %
every week [25]. Most of the participants in this study
acknowledged that excessive antibiotic prescribing is
problematic. They all agreed that some changes are neces-
sary, but questioned whether the PAS is the right vehicle.
Enforcement by government guidelines does not seem to
be an effective way to change physician behavior.
Physicians’ negative perceptions of government policy
seemed to come from various sources, including concerns
about violations of their autonomy and expertise, suspi-
cion about the program’s intention and purpose, distrust
of HIRA, dissatisfaction with notification methods, and
concerns about the publication of results. Physicians
worried that the current PAS would not only promote
conformity to a single standard but would also lower the
quality of medical services. Moreover, as a highly autono-
mous and professional group, participants strongly
objected to a system which results in them being evalu-
ated and compared with others in terms of prescriptions
written, or rates of injections of antibiotics [26, 27].
Interestingly, we found that physicians’ resistance to
perceived violations of their autonomy were often incon-
sistent and contradictory. While they were very positive
about new information or printed materials provided by
pharmaceutical representatives, they were less enthusiastic
about government guidelines or standards. They appear
willing to comply with patient demands as a means of
surviving in a competitive market. Physicians’ inclinations
to readily accept patient demands in making prescribing
decisions has been reported in previous studies [21]. In an
interview with a focus group composed of 24 physicians
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[19], it was found that decisions to prescribe antibiotics
were made in the context of the physician–patient rela-
tionship to prevent potential tension and patients poten-
tially finding other physicians. This implies that an
education campaign for patients may improve the effect-
iveness of the PAS.
Care is necessary when interpreting physicians’ com-
ments that they had no choice but to comply with
patients’ requests for antibiotics, injections, or high-priced
drugs. A qualitative study conducted with 8 physicians
and 42 patients in North Rhine, Germany, showed that
physicians tended to over-assume patient demand for an-
tibiotics [18]. In South Korea, Cho reported that while
73 % of pediatricians thought that patients wanted antibi-
otics, only 2 % of patients expected them [28]. Petursson
conducted qualitative interviews with 16 physicians in
Iceland, and found that unstable physician–patient rela-
tionships, due to a lack of continuity of care, was the most
important reason for prescribing of antibiotics in situa-
tions with low pharmacological indications [17]. Although
several studies have shown that elderly patients in South
Korea prefer injections or antibiotics [29], the claim that
physicians had no choice other than to prescribe high-
priced drugs, injections, or antibiotics due to patient
demand may be somewhat exaggerated.
It is notable that physicians’ negative perceptions of the
PAS seemed to be aggravated by suspicion and distrust
about the purpose of this program. The most appropriate
prescription would be a cost-effective one that provides
high quality medical care at low cost. Participants, how-
ever, seemed to believe that improvement in the quality of
care is only the stated purpose, with cost reduction being
the real goal. Physicians expressed a deeply rooted distrust
of HIRA, the body in charge of the system. They believed
that HIRA’s role is to reduce medication costs by scrutin-
izing their claims and often rejecting their requests for
reimbursements. In fact, the PAS is meant to encourage
physicians to improve their practice autonomously, by
providing information on their prescribing behavior. PAS
is therefore entirely separated from HIRA’s reimbursement
review process. Physicians continued to use negative
terms such as “threat”, “daunted”, and “pressured” to
characterize the PAS, associating the system with their
distrust of HIRA.
Since this study was conducted in 2009, there have been
several changes in government policy, including P4P (Pay
for Performance), which was implemented in 2011;
targeted acute myocardial infarction (AMI); and caesarean
section delivery. In October 2010, the South Korean gov-
ernment introduced a prescribing incentive scheme to
reduce physicians’ prescribing rates, and an online, com-
puterized, prospective drug utilization review (pDUR) has
been in operation since December 2010. This seems to
have had some effect on overuse and misuse of medicines.
Policies that target antibiotic prescription rates for upper
respiratory tract infections, overuse of injections, and
polypharmacy (the number of medications prescribed ≥6),
were implemented in July 2013. Despite this ongoing
introduction of new policies, any change in physicians’
prescribing behavior has yet to be shown. Findings from
studies that have examined the effectiveness of these pol-
icies are not consistent [30, 31]. Despite several interven-
tions since the PAS program started, no research has
shown significant effects on prescribing behavior.
Conclusions
Overall, the results from our study indicate that forming a
social consensus on the purpose of the PAS is the most
critical prerequisite. Physicians do not agree that they are
responsible for cost containment. Participants in our study
felt that maintaining the quality of service was the most
important issue. They view the PAS as a system that forces
physicians to focus on cost rather than quality. Without
narrowing such gaps in perceptions and eliminating
deeply rooted suspicions, any government efforts will con-
tinue to fail.
For HIRA to regain the trust of physicians, it must listen
to them more proactively and have open channels for
receiving comments and inquiries. Physicians place a
higher priority on their professional autonomy and on
market competition than on government surveillance. If
change is to happen, this cannot be overlooked.
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